Lunesta Withdrawal & Tapering Guide
eszopiclone
Boxed Warning
Complex sleep behaviors (boxed warning class effect for Z-drugs).
In short
Lunesta (eszopiclone) is a Z-drug with a half-life of ~6 hours. Slow taper. Withdrawal symptoms, when they occur, usually begin 1-3 days after stopping and settle within 2-6 weeks. It is also sold as Lunivia.
- Class
- Z-drug
- Half-life
- ~6 hours
- Common doses
- 1mg, 2mg, 3mg tablets
- Withdrawal onset
- 1-3 days after stopping
- Typical resolution
- 2-6 weeks
Educational reference only. Dose changes are decided with the prescriber who knows your history.
Overview
Eszopiclone is the active S-isomer of zopiclone, a non-benzodiazepine Z-drug for insomnia. Longer half-life than zolpidem allows it to address sleep-maintenance insomnia, but also increases next-day impairment.
1mg, 2mg, 3mg tablets
Tablets: 1mg, 2mg, 3mg
Category C
Mechanism of Action
Positive allosteric modulator of the GABA-A receptor — less subunit-selective than zolpidem.
Taper Notes
Slow taper. 1mg increments where possible.
Hyperbolic Tapering Guidance
Same approach as other Z-drugs — hyperbolic taper, behavioral sleep tools, manage rebound insomnia without adding another sedative.
Summary written by TaperCommunity, informed by the Maudsley Deprescribing Guidelines (Horowitz & Taylor) and related literature — see Sources & References below. Not affiliated with or endorsed by the Maudsley.
Withdrawal Timeline
1-3 days after stopping
4-7 days
2-6 weeks
Sleep architecture can take 1-3 months to renormalize
Common Withdrawal Symptoms
Interactions & Safety
Drug Interactions
- CNS depressants — additive risk
- Strong CYP3A4 inhibitors — increased exposure
Contraindications
- Prior complex sleep behaviors
- Severe hepatic impairment
Toxicity
Same class effects as zolpidem: complex sleep behaviors, next-day impairment, respiratory depression with CNS depressants. Distinctive metallic/bitter taste.
Pharmacokinetics
ADME Profile
Hepatic via CYP3A4 and CYP2E1.
~52-59%
Need a clinician who understands tapering?
Browse our map of deprescribing-informed providers worldwide.
Other Drug Profiles
The arithmetic of a proportional reduction
The Maudsley Deprescribing Guidelines and NICE NG222 describe reducing benzodiazepines and related drugs by a proportion of the previous dose rather than by a fixed amount, so each cut is smaller than the last. The table shows what that arithmetic produces at 10% per step, using 2 mg only as a worked example. How large each step is, how long it is held, and whether this pattern applies at all are decisions for the person and their prescriber.
| Step | % of starting dose | Worked example (2 mg start) |
|---|---|---|
| Start | 100% | 2 mg |
| Step 1 | 90% | 1.8 mg |
| Step 2 | 81% | 1.62 mg |
| Step 3 | 73% | 1.46 mg |
| Step 4 | 66% | 1.31 mg |
| Step 5 | 59% | 1.18 mg |
| Step 6 | 53% | 1.06 mg |
| Step 7 | 48% | 0.957 mg |
| Step 8 | 43% | 0.861 mg |
This is an illustration of a published method, not a schedule for anyone. It does not account for how long you have taken Lunesta, your current dose, formulation, or history. TaperCommunity does not recommend doses or dose changes; those are agreed with your prescriber.
Frequently asked questions about Lunesta
What are the withdrawal symptoms of Lunesta (eszopiclone)?
Common withdrawal symptoms of Lunesta (eszopiclone) include: rebound insomnia, anxiety, tremor, sweating, GI upset, irritability. Symptom severity varies by individual, dose, and duration of use.
How should I taper off Lunesta (eszopiclone)?
Slow taper. 1mg increments where possible. Same approach as other Z-drugs — hyperbolic taper, behavioral sleep tools, manage rebound insomnia without adding another sedative.
How long does Lunesta withdrawal last?
Lunesta withdrawal typically begins 1-3 days after stopping, peaks around 4-7 days, and resolves within 2-6 weeks. Sleep architecture can take 1-3 months to renormalize
Can I stop Lunesta cold turkey?
Stopping Lunesta abruptly is not recommended. Its half-life is ~6 hours, and the receptor adaptations built up during treatment do not reverse at that speed, so a sudden stop tends to produce the sharpest withdrawal. Prescribing guidance favours gradual, proportional reductions agreed with your prescriber.
How long does Lunesta stay in your system?
Lunesta (eszopiclone) has a half-life of ~6 hours. A drug is mostly cleared after about five half-lives, so Lunesta is largely out of the body about 30 hours after the last dose, longer in older adults or with liver or kidney impairment. Withdrawal symptoms often begin before the drug has fully cleared and continue after it has, because the adaptations the brain made during treatment reverse more slowly than the drug leaves the blood.
Sources & References
Lunesta (eszopiclone) information on this page is sourced from peer-reviewed research, regulatory bodies, clinical guidelines, and patient-advocacy organizations.
Encyclopedic & chemical databases
Neutral, high-authority entity references.
Regulatory sources
Official prescribing information and safety notices.
Peer-reviewed research
Primary literature cited in this taper guide.
- Buscemi N, Vandermeer B, Friesen C, et al. 2007 — The efficacy and safety of drug treatments for chronic insomnia in adults (Journal of General Internal Medicine)
- Lader M 2014 — Benzodiazepine harm: how can it be reduced? (British Journal of Clinical Pharmacology)
- Horowitz MA, Taylor D 2019 — Tapering of SSRI treatment to mitigate withdrawal symptoms (hyperbolic taper) (The Lancet Psychiatry)
Clinical guidelines
Evidence-based deprescribing and prescribing standards.
Deprescribing-specific resources
Clinician-facing references on tapering protocols.
- Deprescribing.org — benzodiazepine receptor agonist algorithm — Evidence-based Z-drug / BZRA deprescribing algorithm
- British National Formulary (BNF) — UK formulary guidance on hypnotic prescribing
- Cochrane Library — Z-drug reviews — Systematic reviews of hypnotic efficacy and safety
Patient-advocacy & lived-experience
Long-running communities documenting withdrawal experience.
- BenzoBuddies — Z-drug section — Peer-support community covering Z-drug tapering
- Benzodiazepine Information Coalition — Education on benzodiazepine-receptor-agonist dependence
- Inner Compass Initiative — Withdrawal Project — Peer-led psychiatric drug withdrawal resources
- Mad in America — sleep medication archive — Journalism on hypnotic prescribing and withdrawal
TaperCommunity does not provide medical advice. Always consult a qualified prescriber before adjusting psychiatric medication.